IMPACT OF SOMATIC MUTATIONS ON OUTCOME IN PATIENTS WITH MDS AFTER STEM-CELL TRANSPLANTATION

被引：0
|
作者：
Yoshizato, T. [1 ,2 ]
Shiozawa, Y. [1 ,3 ]
Yoshida, K. [1 ]
Atsuta, Y. [4 ,5 ]
Yasuhito, N. [6 ]
Suzuki, H. [1 ]
Onizuka, M. [7 ]
Kataoka, K. [1 ]
Chiba, K. [8 ]
Tanaka, H. [9 ]
Shiraishi, Y. [8 ]
Aoki, K. [1 ]
Sanada, M. [10 ]
Itonaga, H. [11 ]
Kanda, Y. [12 ]
Miyazaki, Y. [13 ]
Makishima, H. [1 ]
Miyano, S. [8 ,9 ]
Ogawa, S. [1 ]
机构：
[1] Kyoto Univ, Dept Pathol & Tumor Biol, Kyoto, Japan
[2] Univ Tokyo, Dept Transfus Med, Tokyo, Japan
[3] Univ Tokyo, Dept Pediat, Tokyo, Japan
[4] Nagoya Univ, Dept Healthcare Adm, Nagoya, Aichi, Japan
[5] Japanese Data Ctr Hematopoiet Cell Transplantat, Nagoya, Aichi, Japan
[6] Gifu Univ, Dept Transfus Med, Gifu, Japan
[7] Tokai Univ, Dept Hematol & Oncol, Isehara, Kanagawa, Japan
[8] Univ Tokyo, Lab DNA informat Anal, Ctr Human Genome, Tokyo, Japan
[9] Univ Tokyo, Lab Sequence Anal, Ctr Human Genome, Tokyo, Japan
[10] Nagoya Med Ctr, Clin Res Ctr, Dept Adv Diag, Nagoya, Aichi, Japan
[11] Sasebo City Gen Hosp, Dept Hematol, Sasebo, Japan
[12] Jichi Med Univ, Saitama Med Ctr, Div Hematol, Saitama, Japan
[13] Nagasaki Univ, Atom Bomb Dis Inst, Atom Bomb Dis & Hibakusha Med Unit, Dept Hematol, Nagasaki, Japan
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P241
引用
收藏
页码：67 / 68
页数：2
相关论文
共 50 条
  • [1] Impact of Somatic Mutations on Outcome in Patients with MDS after Stem-Cell Transplantation
    Yoshizato, Tetsuichi
    Shiozawa, Yusuke
    Yoshida, Kenichi
    Atsuta, Yoshiko
    Ito, Chika
    Kataoka, Keisuke
    Onizuka, Makoto
    Suzuki, Hiromichi
    Chiba, Kenichi
    Tanaka, Hiroko
    Shiraishi, Yuichi
    Nagata, Yasunobu
    Sanada, Masashi
    Itonaga, Hidehiro
    Kanda, Yoshinobu
    Miyazaki, Yasushi
    Makishima, Hideki
    Miyano, Satoru
    Ogawa, Seishi
    BLOOD, 2015, 126 (23)
  • [2] Somatic Mutations Predict Poor Outcome in Patients With Myelodysplastic Syndrome After Hematopoietic Stem-Cell Transplantation
    Bejar, Rafael
    Stevenson, Kristen E.
    Caughey, Bennett
    Lindsley, R. Coleman
    Mar, Brenton G.
    Stojanov, Petar
    Getz, Gad
    Steensma, David P.
    Ritz, Jerome
    Soiffer, Robert
    Antin, Joseph H.
    Alyea, Edwin
    Armand, Philippe
    Ho, Vincent
    Koreth, John
    Neuberg, Donna
    Cutler, Corey S.
    Ebert, Benjamin L.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (25) : 2691 - +
  • [3] Prognostic somatic mutations in patients with myelodysplastic syndrome treated with hematopoietic stem-cell transplantation
    Liu, Zixian
    Cao, Shanbo
    Lou, Feng
    Sun, Ying
    Wang, Chengcheng
    Han, Mingzhe
    Jiang, Erlie
    BONE MARROW TRANSPLANTATION, 2019, 54 : 513 - 513
  • [4] Impact of somatic mutations on the outcome of patients allografted for MDS or secondary AML
    Rautenberg, C.
    Germing, U.
    Stepanow, S.
    Lauseker, M.
    Koehrer, K.
    Jaeger, P.
    Geyh, S.
    Schuler, E.
    Haas, R.
    Kobbe, G.
    Schroeder, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 145 - 145
  • [5] Outcome after Hematopoietic Stem Cell Transplantation for Pediatric MDS
    Park, J. A.
    Lim, Y. J.
    Koh, K-N
    Seo, J. J.
    Im, H. J.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S253 - S254
  • [6] Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation
    Lindsley, R. C.
    Saber, W.
    Mar, B. G.
    Redd, R.
    Wang, T.
    Haagenson, M. D.
    Grauman, P. V.
    Hu, Z. -H.
    Spellman, S. R.
    Lee, S. J.
    Verneris, M. R.
    Hsu, K.
    Fleischhauer, K.
    Cutler, C.
    Antin, J. H.
    Neuberg, D.
    Ebert, B. L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (06): : 536 - 547
  • [7] IN PATIENTS UNDEGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR MDS DEVELOPMENT OF CHRONIC GVHD COULD AMELIORATE THE ADVERSE IMPACT OF SPECIFIC SOMATIC MUTATIONS
    Caballero Berrocal, J. C.
    Sanchez Barba, M.
    Hernandez Sanchez, J. M.
    Del Rey, M.
    Janusz, K.
    Chillon, C.
    Such, E.
    Jose, C.
    Sanz, G.
    Hurtado, A. M.
    Calderon Cabrera, C.
    Valcarcel, D.
    Lumbreras, E.
    Robledo, C.
    Abaigar, M.
    Cabrero, M.
    Lopez-Cadenas, F.
    Redondo-Guijo, A.
    Hernandez Rivas, J. M.
    Del Canizo, M. C.
    Diez Campelo, M.
    HAEMATOLOGICA, 2017, 102 : 100 - 101
  • [8] Outcome Improvement After Allogeneic Stem-Cell Transplantation in Myelofibrosis
    Kroeger, Nicolaus
    JOURNAL OF ONCOLOGY PRACTICE, 2016, 12 (07) : 629 - +
  • [9] Molecular Predictors of Outcome in Patients with MDS and AML Following MDS after Allogeneic Hematopoietic Stem Cell Transplantation
    Heuser, Michael
    Koenecke, Christian
    Gabdoulline, Razif
    Loeffeld, Patrick
    Dobbernack, Vera
    Panagiota, Victoria
    Klesse, Sabrina
    Stadler, Michael
    Krauter, Juergen
    Dammann, Elke
    Wichmann, Martin
    Shahswar, Rabia
    Bhuju, Sabin
    Geffers, Robert
    Schlegelberger, Brigitte
    Goehring, Gudrun
    Kleine, Moritz
    Brauns, Wiebke
    Platzbecker, Uwe
    Thiede, Christian
    Schroeder, Thomas
    Kobbe, Guido
    Ganser, Arnold
    Kroeger, Nicolaus
    Thol, Felicitas
    BLOOD, 2015, 126 (23)
  • [10] Impact of comorbidity on the outcome of allogeneic hematopoietic stem cell transplantation in AML/MDS patients.
    Shahjahan, M
    Alamo, J
    Delima, M
    Khouri, I
    Gajewski, J
    Andersson, BS
    Champlin, RE
    Giralt, S
    BLOOD, 2003, 102 (11) : 708A - 708A
12345